weight loss drug prescriptions semaglutide tirzepatide q3 2024 The FDA has approved the first GLP-1 pill for loss, a milestone in the growth of the revolutionary drugs. The drug, a once-a-day Wegovy tablet, is also approved for reducing cardiovascular A wave of new #GLP1

In the pivotal SURMOUNT-1 trial, clinical trials showed average body-weight reduction of roughly 20.9% at the 15mg dose over 72 weeks in adults with obesity who did not have type 2 diabetes

Its an expansive, brain-first view of behavior change

What You Can Do Now If you are currently on a weekly GLP-1 injectable and struggling with adherence , speak with your prescriber about your specific barrier whether that is needle anxiety, scheduling difficulty, or side effects

Mount Olive Seventh-Day Adventist Church has played a vital role in supporting the vision through outreach and coordination

Patients with genetic variants associated with heightened GLP-1R sensitivity may benefit from slower dose escalation or closer monitoring during semaglutide initiation, especially post-diverticulitis